Poliovirus is one of the most human-specific pathogens known to science. Under natural conditions, humans are the only reservoir for the virus, and no wild animal population harbors or transmits it. That said, certain animals, particularly non-human primates, can be infected in laboratory settings, and scientists have even engineered mice to be susceptible by giving them a human gene. The story of which animals can and cannot get polio turns out to reveal a great deal about how the virus works, why global eradication is considered achievable, and what “polio-like” diseases look like in other species.
Why Poliovirus Is So Picky About Its Host
Poliovirus gains entry to human cells by latching onto a surface protein called CD155, also known as the poliovirus receptor. You can think of CD155 as a lock that the virus has a precise key to fit. Every human cell that displays CD155 on its surface is a potential target, with the most consequential targets being motor neurons in the spinal cord, which is where the virus causes the paralysis that defines the disease. Most other mammals either lack CD155 entirely or carry a version of the protein that differs just enough in shape that poliovirus cannot grip it.
Research on primates has shown that susceptibility to poliovirus traces back to specific amino acid changes in the CD155 molecule that occurred along the evolutionary branch leading to simians. A study examining 37 amino acid sites in CD155’s binding domain found that the particular configuration needed for poliovirus to attach evolved through substitutions on the ancestral simian lineage, suggesting that the virus essentially co-evolved with primates over millions of years.1PubMed. Ancient positive selection on CD155 as a possible cause for susceptibility to poliovirus infection in simians Even among primates, though, susceptibility varies dramatically depending on exactly which version of CD155 a species carries.
Non-Human Primates and Experimental Infection
Old World monkeys, especially macaques, have long been used in poliovirus research precisely because they can be infected under controlled conditions. In one large experiment, 39 macaques were each fed a single dose of a highly virulent wild-type poliovirus strain mixed into apple juice. Every animal became infected, shedding virus in their feces. Twelve of the 39 developed overt paralytic disease, with the highest paralysis rates among those given the largest doses.2Journal of Virology. Pathogenic Events in a Nonhuman Primate Model of Oral Poliovirus Infection Leading to Paralytic Poliomyelitis The disease these monkeys developed closely mirrors human poliomyelitis: destruction of motor neurons in the anterior horn of the spinal cord, leading to flaccid paralysis of the limbs.3PubMed. Differential localization of neurons susceptible to enterovirus 71 and poliovirus type 1 in the central nervous system of cynomolgus monkeys after intravenous inoculation
That said, there is a crucial caveat. Macaques are far harder to infect orally than humans are, and the doses needed to produce illness in the lab are enormous compared with what circulates in human-to-human transmission. Research into why has pointed to differences in where CD155 is expressed in the gut. In humans, CD155 appears abundantly in the specialized immune tissue of the intestines, including on microfold cells in Peyer’s patches, which are the very cells that sample material from the gut lumen. In rhesus macaques, this expression pattern differs enough that the virus has a much harder time establishing a productive gut infection through the oral route.4PubMed. Immunofluorescence analysis of poliovirus receptor expression in Peyer’s patches of humans, primates, and CD155 transgenic mice: implications for poliovirus infection So while macaques can get polio, they are not naturally efficient hosts, and there is no evidence that poliovirus circulates among wild primate populations.
New World Monkeys Are Resistant
If Old World monkeys sit somewhere between humans and truly resistant species, New World monkeys like marmosets fall firmly on the resistant side. These primates carry their own version of CD155, but just three amino acid differences in the binding domain are enough to make the marmoset receptor unable to support poliovirus infection. Researchers demonstrated this by swapping those three residues in the marmoset receptor to match the human version. Cells expressing the mutant receptor suddenly became susceptible to poliovirus, confirming that the block is purely a receptor-shape issue rather than some broader immune defense.5PubMed Central. Characterization of the New World monkey homologues of human poliovirus receptor CD155
This finding underlines how specific the virus-receptor interaction is. Three amino acids out of hundreds in a single protein are the difference between a species that can be paralyzed by poliovirus and one that shrugs it off entirely. It also helps explain why the virus never jumped to a broader range of mammalian hosts: the molecular fit required is so precise that even close evolutionary relatives can be naturally immune.
Mice Cannot Get Polio, Unless You Engineer Them
Ordinary laboratory mice are completely resistant to poliovirus. They do not carry CD155, and the virus simply has no way in. But in the early 1990s, researchers created transgenic mice that express the human version of CD155, and these animals became a cornerstone of polio research. When infected, transgenic mice develop a neurological disease that closely mirrors human poliomyelitis, including flaccid paralysis and destruction of spinal motor neurons.6PubMed. A Transgenic Mouse Model of Poliomyelitis Even wild-type mice, which normally cannot be infected, show similar motor neuron destruction when poliovirus is introduced directly into the central nervous system, bypassing the need for a receptor-mediated entry step.7PubMed. The neuropathology observed in wild-type mice inoculated with human poliovirus mirrors human paralytic poliomyelitis
Among the transgenic mouse models, different strains vary in susceptibility depending on where and how much CD155 is expressed. One line called TgPVR21, which expresses CD155 driven by the human promoter, can be infected intranasally: at certain doses, more than 40% of mice developed flaccid paralysis of the limbs within about a week.8Virology. A poliomyelitis model through mucosal infection in transgenic mice bearing human poliovirus receptor, TgPVR21 A different strain using a gut-specific promoter showed even higher susceptibility to oral infection in younger mice, which was notable because oral infection is the natural route in humans and had been difficult to reproduce in mice.9PubMed Central. Poliomyelitis in transgenic mice expressing CD155 under the control of the Tage4 promoter after oral and parenteral poliovirus inoculation
These mouse models have become valuable partly because they reduce the need for primate experiments in vaccine development and safety testing. Engineered cell lines have followed a similar logic. A mouse cell line called L20B, modified to express human CD155, has proven at least as sensitive as the primary monkey kidney cells traditionally used to detect live poliovirus in vaccine preparations.10PubMed Central / Elsevier. Replacement of primary monkey kidney cells by L20B cell line in the test for effective inactivation of inactivated poliovirus vaccine
Vaccine Safety Testing and the Monkey Connection
For decades, live oral poliovirus vaccine (OPV) has been tested for safety by injecting it into the brains or spinal cords of macaques and watching for signs of neurological disease. This monkey neurovirulence test (MNVT) was designed to confirm that the weakened vaccine strains had not reverted toward a more dangerous form. Both rhesus and cynomolgus macaques have been used for this purpose.11Vaccine. Neurovirulence tests of type 3 oral poliovirus vaccine manufactured by Lederle Laboratories, 1964–1988
Ethical concerns about using primates, combined with doubts about how well the monkey test predicts actual risk in humans, have driven a long effort to develop alternatives. These include transgenic mouse models, engineered cell lines, and molecular assays that detect dangerous mutations in the vaccine virus’s genetic sequence without any animal testing at all.12Procedia in Vaccinology. Toward replacement of the monkey neurovirulence test in vaccine safety testing Research on vaccine strains has shown that certain mutations accumulate when the virus is passaged repeatedly in cell culture, including reversions at key positions that could theoretically restore virulence, though high-passage stocks have still managed to pass the MNVT despite containing substantial amounts of these mutations.13PubMed Central. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype The fact that monkeys can serve as sentinels for dangerous vaccine reversion is one of the few practical reasons their susceptibility to poliovirus has mattered outside of basic research.
Why No Animal Reservoir Makes Eradication Possible
The reason global health authorities consider polio eradicable, in the same category as smallpox, rests heavily on the fact that no animal population maintains the virus. The biological principles are straightforward: poliovirus causes acute infections (it does not persist indefinitely in a carrier), it is transmitted by infected humans or their waste, it survives in the environment for a limited time, and humans are the only reservoir. If you vaccinate enough people to interrupt transmission, the virus has nowhere to hide.14PubMed Central. The biologic principles of poliovirus eradication
Compare this with diseases like influenza, where animal reservoirs in birds and pigs continuously generate new strains that can jump back to humans. Or consider yellow fever, which circulates in primate populations in tropical forests and can spill over into human outbreaks regardless of vaccination coverage. Poliovirus has none of these complications. The absence of a non-human reservoir, combined with the availability of effective vaccines, is precisely what has made eradication a viable public health strategy.15PubMed Central. Disease eradication as a public health strategy: a case study of poliomyelitis eradication
This also means that concerns about poliovirus “hiding” in wildlife and re-emerging are unfounded. The virus cannot establish itself in any wild animal population. The remaining challenges for eradication are entirely human: reaching unvaccinated communities, managing vaccine-derived virus strains that circulate in under-immunized populations, and maintaining surveillance.
Polio-Like Diseases in Other Animals
While poliovirus itself does not infect livestock or poultry, other viruses in the same broad family cause strikingly similar diseases in animals. These are not polio, but they can look like it clinically, which has occasionally caused confusion.
Pigs have their own enterovirus problem. Porcine teschovirus, particularly the virulent type 1 strains, caused devastating outbreaks of nonsuppurative encephalomyelitis in pigs across Central Europe from the 1930s through the 1950s. Known as Teschen disease, this condition produced paralysis and high fatality rates and was in many ways the porcine equivalent of paralytic poliomyelitis, though the viruses responsible are genetically distinct from human poliovirus.16PubMed. The role of porcine teschovirus in causing diseases in endemically infected pigs
Chickens face avian encephalomyelitis virus (AEV), a positive-sense RNA virus that also belongs to the Picornaviridae family and is classified within the Enterovirus genus. AEV can cause tremors, ataxia, and paralysis in young chicks. Serological surveys of backyard poultry have detected antibodies to AEV in roughly 15% of chickens tested, while pigeons and doves in the same study showed no evidence of infection.17Veterinary World. Avian encephalomyelitis virus in backyard chickens Like porcine teschovirus, AEV is related to poliovirus only in the sense that both are enteroviruses. There is no cross-infection risk between species, and neither of these animal viruses poses any threat to humans.
These parallels matter because they illustrate that the enterovirus family is ancient and diverse. Many mammalian and avian species have their own enteroviruses that can attack the nervous system, but each virus is adapted to its own host species. Poliovirus is simply the human member of this broader pattern.
Wild Enteroviruses and Great Apes
One intriguing case blurs the line between “polio” and “polio-like disease in animals.” In 2014, researchers reported the first detection of an enterovirus C99, a member of the same viral species as poliovirus (Enterovirus C), in a captive chimpanzee that had developed acute flaccid paralysis at a rehabilitation center in the Republic of Congo. Genetic analysis showed the virus was closely related to enterovirus C99 strains previously found in humans in Cameroon and Bangladesh.18PLOS ONE. First Detection of an Enterovirus C99 in a Captive Chimpanzee with Acute Flaccid Paralysis, from the Tchimpounga Chimpanzee Rehabilitation Center, Republic of Congo
This was not poliovirus itself, but enterovirus C99 belongs to the same viral species and can cause a clinically indistinguishable paralytic syndrome. The finding raised questions about the potential for cross-species transmission of enteroviruses between humans and great apes, especially in settings where the two are in close contact. Broader serological surveys have confirmed that apes and Old World monkeys carry antibodies to a range of enteroviruses, some of which cluster with human enterovirus species A and B.19Emerging Infectious Diseases. High Seroprevalence of Enterovirus Infections in Apes and Old World Monkeys
None of this changes the fundamental picture for poliovirus eradication. Poliovirus serotypes 1, 2, and 3 remain exclusively human pathogens in the wild. But the enterovirus C species is broader than poliovirus alone, and great apes living near humans appear to be exposed to some of its members. Whether these infections ever cause significant disease in wild ape populations, or whether they are dead-end spillovers from human contact, is still an open question. For the polio eradication program, the critical point remains that the three poliovirus serotypes do not maintain themselves in any animal population, even among our closest relatives.